Literature DB >> 1914375

Grapefruit juice and cimetidine inhibit stereoselective metabolism of nitrendipine in humans.

P A Soons1, B A Vogels, M C Roosemalen, H C Schoemaker, E Uchida, B Edgar, J Lundahl, A F Cohen, D D Breimer.   

Abstract

The effects of grapefruit juice (150 ml at -15, -10, -1/4, +5, and +10 hours) and cimetidine (200 mg at the same times) on the stereoselective pharmacokinetics and effects of 20 mg oral racemic nitrendipine were investigated in a placebo-controlled crossover study in nine healthy men. In all subjects the AUC of racemic nitrendipine was increased by grapefruit juice (mean increase 106%; 95% confidence interval 64% to 158%) and cimetidine treatment (+154%; 95% confidence interval 77% to 265%). Comparable results were obtained for the peak plasma drug concentration and for both parameters of (S)- and (R)-nitrendipine. There were highly significant differences in the area under the concentration-time curve and peak plasma drug concentration between enantiomers within all treatments. Grapefruit juice had no effect on this stereoselectivity, but cimetidine increased the mean S/R ratio of areas under the curve (2.25) by 20% (95% confidence interval 12% to 29%) compared with placebo treatment (1.89). Half-lives and time to reach peak concentration of the enantiomers were not different within and between treatments. There were no consistent effects on blood pressure with all treatments, but in most subjects there was a small temporary increase in heart rate after intake of nitrendipine. Grapefruit juice and cimetidine did not affect these hemodynamic parameters and did not cause additional adverse effects.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1914375     DOI: 10.1038/clpt.1991.156

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  32 in total

1.  Pharmacokinetic analysis of felodipine-grapefruit juice interaction based on an irreversible enzyme inhibition model.

Authors:  H Takanaga; A Ohnishi; H Matsuo; H Murakami; H Sata; K Kuroda; A Urae; S Higuchi; Y Sawada
Journal:  Br J Clin Pharmacol       Date:  2000-01       Impact factor: 4.335

2.  Interaction between grapefruit juice and praziquantel in humans.

Authors:  Nelly Castro; Helgi Jung; Roberto Medina; Dinora González-Esquivel; Mario Lopez; Julio Sotelo
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

3.  Acute effects of drinking grapefruit juice on the pharmacokinetics and dynamics of felodipine--and its potential clinical relevance.

Authors:  B Edgar; D Bailey; R Bergstrand; G Johnsson; C G Regårdh
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

4.  Stereoselective interaction of manidipine and grapefruit juice: a new twist on an old tale.

Authors:  Brian Tomlinson; Moses S S Chow
Journal:  Br J Clin Pharmacol       Date:  2006-05       Impact factor: 4.335

Review 5.  Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance.

Authors:  U Fuhr
Journal:  Drug Saf       Date:  1998-04       Impact factor: 5.606

Review 6.  Undesirable effects of citrus juice on the pharmacokinetics of drugs: focus on recent studies.

Authors:  Mitsuo Saito; Mutsuko Hirata-Koizumi; Mariko Matsumoto; Tsutomu Urano; Ryuichi Hasegawa
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

7.  Grapefruit juice inhibits 7-hydroxylation of coumarin in healthy volunteers.

Authors:  U Merkel; H Sigusch; A Hoffmann
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

Review 8.  Grapefruit juice-drug interactions.

Authors:  D G Bailey; J Malcolm; O Arnold; J D Spence
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

9.  In vitro inhibition of midazolam and quinidine metabolism by flavonoids.

Authors:  H R Ha; J Chen; P M Leuenberger; A U Freiburghaus; F Follath
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 10.  Influence of diet and nutritional status on drug metabolism.

Authors:  I Walter-Sack; U Klotz
Journal:  Clin Pharmacokinet       Date:  1996-07       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.